What hematological effects, like reduced platelet aggregation or bleeding risk, are linked to omeprazole and how can these effects be managed during treatment in patients at risk?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Omeprazole can increase bleeding risk by reducing platelet aggregation. Monitor patients closely and consider adjusting doses for those taking anticoagulants.